ATAI Life Sciences NV
NASDAQ:ATAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
DE |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
Hiro Brands Ltd
ASX:HRO
|
AU |
|
T
|
Thaivivat Insurance PCL
SET:TVI
|
TH |
|
G
|
Grupo Concesionario del Oeste SA
BCBA:OEST
|
AR |
|
L
|
Lithium Ionic Corp
XTSX:LTH
|
CA |
|
Brioschi Sviluppo Immobiliare SpA
MIL:BRI
|
IT |
|
O
|
Oversea Enterprise Bhd
KLSE:OVERSEA
|
MY |
|
M
|
mPlus Corp
KOSDAQ:259630
|
KR |
|
electroCore, Inc.
NASDAQ:ECOR
|
US |
|
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
|
US |
|
Mayur Resources Ltd
ASX:MRL
|
AU |
|
S
|
Sabina PCL
SET:SABINA
|
TH |
|
V
|
VSTECS Holdings Ltd
HKEX:856
|
HK |
|
American Superconductor Corp
NASDAQ:AMSC
|
US |
Wall Street
Price Targets
ATAI Price Targets Summary
ATAI Life Sciences NV
According to Wall Street analysts, the average 1-year price target for
ATAI
is 13.72 USD
with a low forecast of 7.07 USD and a high forecast of 26.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ATAI's stock price target?
Price Target
13.72
USD
According to Wall Street analysts, the average 1-year price target for
ATAI
is 13.72 USD
with a low forecast of 7.07 USD and a high forecast of 26.25 USD.
What is ATAI Life Sciences NV's Revenue forecast?
Projected CAGR
29%
The
compound annual growth rate
of ATAI Life Sciences NV's revenue for the next 3 years is
29%.
